Is a complete ALMR research report available?

No complete published report is available for Alamar Biosciences, Inc. (ALMR) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Alamar Biosciences, Inc. (ALMR)

NASDAQ: ALMR · USD

$34.1

+2.14 (+6.7%)· Recorded snapshot

Market cap	2.4B
Revenue (ttm)	100.4M
Net income (ttm)	-49.7M
EPS (ttm)	-$2.10
Shares out	69.4M
Volume	1,031,014

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 100.4M
Net income (ttm): -49.7M
EPS (ttm): -$2.10
Market cap: 2.4B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Halten

Metric	Value
Amount currency	USD
CIK code	0002104204
Company name	Alamar Biosciences, Inc.
Country	United States
Country code	US
CUSIP number	010911105
Earnings date	2026-11-03
Earnings time	amc
Employees	286
Enterprise value	$2.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
In index	RUSSELL2000
Industry	Medical Devices
IPO date	2026-04-17
Is primary listing	Yes
Is SPAC	No
ISIN number	US0109111056
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.4B
Market cap category	Mid-Cap
Next earnings date	2026-11-03
Options	No
Price	$34.07
Price currency	USD
Sector	Healthcare
SIC code	3826
Stock price date	2026-10-28
Symbol	ALMR
Tags	pharmaceuticals
U.S. state	California
Website	https://alamarbio.com

Metric

Value

Amount currency

USD

CIK code

0002104204

Company name

Alamar Biosciences, Inc.

Country

United States

Country code

CUSIP number

010911105

Earnings date

2026-11-03

Earnings time

amc

Employees

286

Enterprise value

$2.2B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

In index

RUSSELL2000

Industry

Medical Devices

IPO date

2026-04-17

Is primary listing

Yes

Is SPAC

ISIN number

US0109111056

Last earnings date

2026-08-10

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$2.4B

Market cap category

Mid-Cap

Next earnings date

2026-11-03

Options

Price

$34.07

Price currency

USD

Sector

Healthcare

SIC code

3826

Stock price date

2026-10-28

Symbol

ALMR

Tags

pharmaceuticals

U.S. state

California

Website

https://alamarbio.com

Metric	Value
Earnings yield	-6.16%
EV/Sales	20.98x
FCF / EV yield	-3.26%
FCF yield	-2.98%
Forward EV/Sales	15.16x
Forward P/S	16.59x
Industry forward P/E	19.74x
Industry P/E	39.16x
P/B ratio	7.08x
P/S ratio	22.96x
Price / tangible book value	7.41x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-6.16%

EV/Sales

20.98x

FCF / EV yield

-3.26%

FCF yield

-2.98%

Forward EV/Sales

15.16x

Forward P/S

16.59x

Industry forward P/E

19.74x

Industry P/E

39.16x

P/B ratio

7.08x

P/S ratio

22.96x

Price / tangible book value

7.41x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-40.57%
EBITDA margin	-37.33%
Gross margin	58.66%
Operating margin	-40.57%
Pretax margin	-48.42%
Profit margin	-49.45%
Profit per employee	$-173,640
Revenue per employee	$351,119
ROCE	-11.22%
SBC / revenue	6.29%
Tax / revenue	1.03%

Metric

Value

EBIT margin

-40.57%

EBITDA margin

-37.33%

Gross margin

58.66%

Operating margin

-40.57%

Pretax margin

-48.42%

Profit margin

-49.45%

Profit per employee

$-173,640

Revenue per employee

$351,119

ROCE

-11.22%

SBC / revenue

6.29%

Tax / revenue

1.03%

Metric	Value
EPS growth quarters	1
EPS growth years	1
Net income growth years	1
Revenue growth	195.17%
Revenue growth (Q)	82.08%
Revenue growth (QoQ)	13.03%
Revenue growth quarters	1
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth

195.17%

Revenue growth (Q)

82.08%

Revenue growth (QoQ)

13.03%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-8.3M
Depreciation and amortization	$3.3M
EBIT	$-40.7M
EBITDA	$-37.5M
EPS	$-2.10
FCF per share	$-0.99
Financing cash flow	$268M
Free cash flow	$-68.6M
Free cash flow minus SBC	$-75M
Gross profit	$58.9M
Income taxes	$1M
Investing cash flow	$-110.4M
Net borrowing	$60.4M
Net cash flow	$96.7M
Net income	$-49.7M
Operating cash flow minus SBC	$-66.6M
Operating income	$-40.7M
Revenue	$100.4M
Stock-based compensation	$6.3M

Metric

Value

Capital expenditures

$-8.3M

Depreciation and amortization

$3.3M

EBIT

$-40.7M

EBITDA

$-37.5M

EPS

$-2.10

FCF per share

$-0.99

Financing cash flow

$268M

Free cash flow

$-68.6M

Free cash flow minus SBC

$-75M

Gross profit

$58.9M

Income taxes

$1M

Investing cash flow

$-110.4M

Net borrowing

$60.4M

Net cash flow

$96.7M

Net income

$-49.7M

Operating cash flow minus SBC

$-66.6M

Operating income

$-40.7M

Revenue

$100.4M

Stock-based compensation

$6.3M

Metric	Value
Altman Z-Score	12.1
Book value per share	$4.51
Debt / equity	0.16
Interest coverage	-54.03
Long-term assets	$59.6M
Long-term liabilities	$50.2M
Net cash (debt)	$198.6M
Net cash / market cap	8.61%
Net debt / equity	-0.63
Piotroski F-Score	0
Property, plant and equipment	$49.2M
Shareholders' equity	$312.9M
Tangible book value	$311.3M
Tangible book value per share	$4.49
Total assets	$391M
Total cash	$250.1M
Total debt	$51.4M
Total liabilities	$78.1M

Metric

Value

Altman Z-Score

12.1

Book value per share

$4.51

Debt / equity

0.16

Interest coverage

-54.03

Long-term assets

$59.6M

Long-term liabilities

$50.2M

Net cash (debt)

$198.6M

Net cash / market cap

8.61%

Net debt / equity

-0.63

Piotroski F-Score

Property, plant and equipment

$49.2M

Shareholders' equity

$312.9M

Tangible book value

$311.3M

Tangible book value per share

$4.49

Total assets

$391M

Total cash

$250.1M

Total debt

$51.4M

Total liabilities

$78.1M

Metric	Value
Current assets	$331.4M
Current liabilities	$28M
Current ratio	11.85
Net working capital	$55.6M
Quick ratio	9.67
Working capital	$303.4M

Metric

Value

Current assets

$331.4M

Current liabilities

$28M

Current ratio

11.85

Net working capital

$55.6M

Quick ratio

9.67

Working capital

$303.4M

Metric	Value
Dividend yield	0%

Metric

Value

Dividend yield

Metric	Value
1D price change	6.7%
1M price change	2.35%
1M total return	2.35%
1W price change	19.21%
1W total return	19.21%
20-day SMA	$29.21
3M price change	37.58%
3M total return	37.58%
50-day SMA	$30.74
52-week high	$39.61
52-week high date	2026-10-06
52-week low	$18.85
52-week low date	2026-05-26
6M price change	25.78%
6M total return	25.78%
All-time high	$39.61
All-time high date	2026-10-06
All-time low	$18.85
All-time low date	2026-05-26
Average true range (ATR)	$2.59
Average volume	783K
Beta (1Y)	-0.66
Change from 52-week high	-13.99%
Change from 52-week low	80.79%
Change from all-time high	-15.25%
Change from all-time low	78.14%
Change from open	6.5%
Day's gap	0.19%
Dollar volume	$35.1M
High price	$34.18
Low price	$31.99
Monthly RSI	0
Open price	$31.99
Position in 52-week range	94.98%
Premarket change	0%
Premarket close	$31.93
Premarket price	$31.93
Previous close	$31.93
Price vs 20-day SMA	14.93%
Price vs 50-day SMA	9.19%
Relative volume	1.32
Return from IPO open	47.04%
Return from IPO price	95.47%
RSI	58.85
Sharpe ratio	1.29
Sortino ratio	2.23
Volume	1M
Weekly RSI	59.88

Metric

Value

1D price change

6.7%

1M price change

2.35%

1M total return

2.35%

1W price change

19.21%

1W total return

19.21%

20-day SMA

$29.21

3M price change

37.58%

3M total return

37.58%

50-day SMA

$30.74

52-week high

$39.61

52-week high date

2026-10-06

52-week low

$18.85

52-week low date

2026-05-26

6M price change

25.78%

6M total return

25.78%

All-time high

$39.61

All-time high date

2026-10-06

All-time low

$18.85

All-time low date

2026-05-26

Average true range (ATR)

$2.59

Average volume

783K

Beta (1Y)

-0.66

Change from 52-week high

-13.99%

Change from 52-week low

80.79%

Change from all-time high

-15.25%

Change from all-time low

78.14%

Change from open

6.5%

Day's gap

0.19%

Dollar volume

$35.1M

High price

$34.18

Low price

$31.99

Monthly RSI

Open price

$31.99

Position in 52-week range

94.98%

Premarket change

Premarket close

$31.93

Premarket price

$31.93

Previous close

$31.93

Price vs 20-day SMA

14.93%

Price vs 50-day SMA

9.19%

Relative volume

1.32

Return from IPO open

47.04%

Return from IPO price

95.47%

RSI

58.85

Sharpe ratio

1.29

Sortino ratio

2.23

Volume

Weekly RSI

59.88

Metric	Value
Float	41.1M
Float percentage	59.27%
Shares change (QoQ)	378.52%
Shares held by insiders	10.44%
Shares held by institutions	35.37%
Shares outstanding	69.4M
Short % of float	6.83%
Short % of shares	4.05%
Short ratio	6 days

Metric

Value

Float

41.1M

Float percentage

59.27%

Shares change (QoQ)

378.52%

Shares held by insiders

10.44%

Shares held by institutions

35.37%

Shares outstanding

69.4M

Short % of float

6.83%

Short % of shares

4.05%

Short ratio

6 days

Alamar Biosciences, Inc. (ALMR)

Price

Financial snapshot

Fair-value bridge

Latest news · ALMR

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ALMR indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ALMR

Frequently asked questions